615568-69-9

Basic information

• Product Name: methyl 7-oxo-1,5,6,7-tetrahydro-1,8-naphthyridine-2-carboxylate
• Synonyms: methyl 7-oxo-1,5,6,7-tetrahydro-1,8-naphthyridine-2-carboxylate;methyl 7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridine-2-carboxylate
• CAS NO: 615568-69-9
• Molecular Formula: C10H10N2O3
• Molecular Weight: 206.198
• Mol File: 615568-69-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl 7-oxo-1,5,6,7-tetrahydro-1,8-naphthyridine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 7-oxo-1,5,6,7-tetrahydro-1,8-naphthyridine-2-carboxylate(615568-69-9)
• EPA Substance Registry System: methyl 7-oxo-1,5,6,7-tetrahydro-1,8-naphthyridine-2-carboxylate(615568-69-9)

Safety Data

• Hazardous Substances Data: 615568-69-9(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 15944-34-0 7-chloro-1,8-naphthyridin-2(1H)-one 
• 615568-68-8 6-amino-5-(2-ethoxycarbonyl-ethyl)-pyridine-2-carboxylic acid methyl ester 

Downstream Products

• 615568-70-2 7-oxo-5,6,7,8-tetrahydro-[1,8]naphthryridine-2-carboxylic acid 

Relevant articles and documents

ANTIBACTERIAL AGENTS

Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.

[1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS WITH KETO OR HYDROXYL LINKERS FOR THE TREATMENT OF SCHIZOPHRENIA

Compounds of formula (I) are disclosed. A of formula 1 is -(CH2)mCO- or -(CH2)mCOH-, wherein m is an integer from 2 to 5 and wherein one or two of the carbon atoms can be substituted as described in the specification. G, D, Z, Q, X, Y, R1, and R4 through R7 of formula 1 are defined in the specification. Also provided are descriptions of processes for preparing compounds of formula 1, intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.

NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS

Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.